Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni.
Open Access
- 1 September 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 172 (3) , 1001-1004
- https://doi.org/10.1084/jem.172.3.1001
Abstract
A monoclonal antibody (mAb) directed against a synthetic peptide derived from the sequence of the human immunodeficiency virus type 1 (HIV-1) regulatory protein virion infectivity factor (vif) labeled the surface of Schistosoma mansoni schistosomula by indirect immunofluorescence. Western blotting showed that two S. mansoni proteins of 170 and 65 kD were recognized by the mAb. Sera from 20% of S. mansoni-infected HIV-seronegative individuals tested recognized the PS4 peptide in an ELISA as did sera from S. mansoni-infected rats. Sera from individuals seropositive for HIV-1, but without schistosomiasis, that reacted with the vif peptide also recognized a 170-kD S. mansoni protein. This crossreactive S. mansoni antigen appears to be a target of immunity in vivo since passive transfer of the mAb VIF-CD3 to naive rats had a protective effect against a challenge infection with S. mansoni cercariae.This publication has 14 references indexed in Scilit:
- Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni.The Journal of Immunology, 1989
- Antibodies to thenefProtein and tonefPeptides in HIV-1—Infected Seronegative IndividualsAIDS Research and Human Retroviruses, 1989
- Absence of cross-reactivity between Schistosoma mansoni infection and human immunodeficiency virus (HIV)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Isotypic Restriction of the Antibody Response to Human Immunodeficiency VirusAIDS Research and Human Retroviruses, 1988
- HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene productNature, 1987
- Replicative and Cytopathic Potential of HTLV-III/LAV with sor Gene DeletionsScience, 1986
- ELISA HTLV RETROVIRUS ANTIBODY REACTIVITY ASSOCIATED WITH MALARIA AND IMMUNE COMPLEXES IN HEALTHY AFRICANSThe Lancet, 1985
- Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East AfricaInternational Journal of Cancer, 1985
- Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responsesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult wormsParasitology, 1965